Abstract:Proc Amer Assoc Cancer Res, Volume 47, 2006 4874 IFNγ is a key immunomodulator pivotal in the host defense against tumor progression. Pionnering studies have demonstrated that IFNγ mediated-signaling pathways are critical against tumor development in recombination activation gene deficient mice. Here we show that the main source of IFNγ is not the conventional NK cell but a subset of B220+Ly6C- dendritic cells that are atypical in thus far that they express NK cell surface molecules (Dx5, NK1.1, NKG2D, Ly49). They represent 1% of splenic CD11c+ cells in naive animals, can be expanded by 5 fold by immunotherapy combining c-kit tyrosine kinase inhibitors and IL-2 or Flt3L and traffick into tumor beds where they constitute up to 20% of tumor infiltrating CD11c+. Upon contact with a variety of tumor cells that are poorly recognized by NK cells, B220+NK1.1+ dendritic cells secrete high levels of IFNγ and mediate TRAIL-dependent tumor cell lysis. During therapy with imatinib mesylate and IL-2, tumor regression depends on TRAIL molecules, NK1.1 expressing cells and IFN type II receptors, suggesting a role for B220+NK1.1+ dendritic cells in tumor shrinkage. Adoptive transfer of these Interferon-producing Killer Dendritic Cells (IKDC) into tumor-bearing Rag-/-IL-2Rγ-/- mice prevented tumor outgrowth whereas conventional NK cells failed to do so. IKDC can be found in Rag-/-IL-2Rγ-/- mice, they diverge from the NK cell lineage. Moreover, they exhibit a typical morphology distinguishable from classical myeloid DC or plasmacytoid DC or NK cells and are capable of antigen presentation following TLR4 and 9 triggering. We identified IKDC as pivotal sensors and effectors of the innate anti-tumor immune response (Taieb J et al Nature Medicine, in revision in back to back with D.Pardoll’s manuscript).

Natural Killer Cell Behavior in Lymph Nodes Revealed by Static and Real-Time Imaging

Dynamics of NK cell interactions in vivo

NK cells at the interface between innate and adaptive immunity

The Reciprocal Interactions between Natural Killer Cells and Dendritic Cells

Natural killer cells are the regulators of T cell immunity

Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

Natural Killer Cells: Development, Maturation, and Clinical Utilization

Natural killer cells in the central nervous system

NK Cells Promote Type 1 T Cell Immunity Through Modulating the Function of Dendritic Cells During Intracellular Bacterial Infection

Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG)

Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection

Natural Killer-like B Cells Prime Innate Lymphocytes Against Microbial Infection.

Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.

On blood and tissue-resident natural killer cells

Natural killer cells and type 1 innate lymphoid cells in cancer

A Novel Dendritic Cell Subset Supporting the Concept of Tumor Immunoediting: Ifn Producing Killer Dendritic Cell (Ikdc)

Intravital Imaging of B Cell Responses in Lymph Nodes

Natural killer T cells are critical for dendritic cells to induce immunity in Chlamydial pneumonia

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization

Novel mouse NK progenitors in lymph node: developmental origin and functional contributions. (138.1)

Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia